logo
Sanofi to Buy Vicebio for Up to $1.6 Billion in Respiratory Push

Sanofi to Buy Vicebio for Up to $1.6 Billion in Respiratory Push

Bloomberg15 hours ago
Sanofi agreed to buy UK vaccine developer Vicebio Ltd. for as much as $1.6 billion, as it seeks to expand in respiratory treatments.
The pharmaceutical firm will pay $1.15 billion upfront, with potential milestone payments of up to $450 million based on development and regulatory achievements, according to a statement Tuesday. Vicebio is developing an early-stage combination vaccine candidate for respiratory syncytial virus, or RSV, and human metapneumovirus (hMPV), the company said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025

Yahoo

time4 minutes ago

  • Yahoo

Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025

PIOMBINO DESE, Italy, July 22, 2025--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the second quarter of 2025 on Tuesday, August 5, 2025, at 6:30 a.m. (ET). Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Tuesday, August 5, 2025, to discuss financial results. During the call, management will refer to a slide presentation which will be available on the morning of the call on the "Financial Results" page under the Company's Investor Relations section of its website. Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. We encourage participants to pre-register for the conference call using the following link: STVN conference call pre-registration. Webcast: A live, listen-only webcast of the call will be available at the following link: STVN webcast. Dial in: Those who are unable to pre-register may dial in by calling: Italy: +39 02 802 09 11 United Kingdom: +44 1 212 818004 United States: +1 718 705 8796 United States Toll Free: +1 855 265 6958 Questions during the call: Participants who wish to ask questions during the call should use the HD webphone link: Replay: The webcast will be archived for three months on the Company's Investor Relations section of its website. About Stevanato Group Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation, and its engineering excellence are central to its ability to offer value-added solutions to clients. To learn more, visit: View source version on Contacts Investor Relations Lisa Miles: Media media@

Book Review: 'The Sleep Room' is the harrowing story of psychiatric care in the 1960s
Book Review: 'The Sleep Room' is the harrowing story of psychiatric care in the 1960s

Yahoo

time4 minutes ago

  • Yahoo

Book Review: 'The Sleep Room' is the harrowing story of psychiatric care in the 1960s

Book Review: 'The Sleep Room' is the harrowing story of psychiatric care in the 1960s This image released by Abrams Books shows "The Sleep Room" by Jon Stock. (Abrams Books via AP) In the 1960s, a hospital in London held a ward full of women who suffered from a range of mental disorders. The women in this 'sleep room' were subjected to various medical procedures, including electroconvulsive therapy, or ECT, and, at times, a lobotomy, without their consent. In "The Sleep Room: A Sadistic Psychiatrist and the Women Who Survived Him,' Jon Stock tells the harrowing history of the British doctor who subjected them to medical abuse and gives voice to those who survived him. With interwoven firsthand testimony from surviving patients and rigorous research, Stock provides a haunting account of what the psychiatrist did to his patients without their knowledge. Throughout the book Stock also works to hold the medical establishment accountable for the neglect that occurred, but at times can simplify the complexities of psychiatric care during the '60s that most likely led to the abuse endured by many patients. ADVERTISEMENT While the switching between patient stories, history and research can create some confusion for the reader, the patient testimonies allows Stock to deliver an emotionally powerful narrative that is equally as disturbing. Written with nuance and tact, the 'The Sleep Room' is a chilling exposé into psychiatric care that will resonate deeply readers and, especially, true crime fans. ___ AP book reviews:

Parkinson's disease charities praise Ozzy Osbourne's openness about condition
Parkinson's disease charities praise Ozzy Osbourne's openness about condition

Yahoo

time4 minutes ago

  • Yahoo

Parkinson's disease charities praise Ozzy Osbourne's openness about condition

Parkinson's disease charities have praised Ozzy Osbourne for talking about his diagnosis and helping others 'feel less alone' in facing the challenges of the condition. Parkinson's UK said the Black Sabbath frontman 'normalised tough conversations', while Cure Parkinson's thanked him for 'putting a spotlight' on its work. The proceeds of the Black Sabbath reunion earlier this month went to Cure Parkinson's, Birmingham Children's Hospital and Acorns Children's Hospice. In 2020, Osbourne revealed he had been diagnosed with Parkinson's disease and he paused touring in 2023 after extensive spinal surgery. ADVERTISEMENT He had a fall at home in 2019 which aggravated injuries from a near-fatal quad bike crash in 2003. Parkinson's UK chief executive Caroline Rassell said: 'News of Ozzy Osbourne's death, so soon after his celebratory homecoming show, will come as a shock to so many. 'By speaking openly about both his diagnosis and life with Parkinson's, Ozzy and all his family helped so many families in the same situation. 'They normalised tough conversations and made others feel less alone with a condition that's on the rise and affecting more people every day. 'All of our heartfelt thoughts are with his family, friends and fans worldwide. His memory and the impact he left on the world will live on in all of them.' Helen Matthews, chief executive of Cure Parkinson's, said: 'We are devastated to hear the news about Ozzy and all our thoughts are with Sharon and his family. ADVERTISEMENT 'It seems incredible that a couple of short weeks ago Ozzy, Black Sabbath and all the acts that contributed to Back to the Beginning produced the most phenomenal and vibrant concert at Villa Park. 'We are so grateful to Ozzy for all he has done to put a spotlight on the work of Cure Parkinson's, Birmingham children's Hospital and Acorns Children's Hospice. 'On behalf of us all at Cure Parkinson's – thank you.' Osbourne said earlier this year that the last six years had been 'full of some of the worst times I've been through'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store